Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 9, Pages 3705-3715
Publisher
The American Association of Immunologists
Online
2016-10-04
DOI
10.4049/jimmunol.1600909
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis
- (2016) Hemant K Mishra et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Proteolytic Cleavage Governs Interleukin-11 Trans-signaling
- (2016) Juliane Lokau et al. Cell Reports
- “Family reunion” – A structured view on the composition of the receptor complexes of interleukin-6-type and interleukin-12-type cytokines
- (2015) Stefan Rose-John et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-6: Biology, signaling and strategies of blockade
- (2015) Fred Schaper et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles
- (2015) Neele Schumacher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses
- (2015) Isabell Yan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis
- (2014) V. Caolo et al. ANGIOGENESIS
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space
- (2014) J. Pruessmeyer et al. BLOOD
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle shedding
- (2014) Timo Effenberger et al. FASEB JOURNAL
- Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis
- (2014) JAN SOMMER et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- The Role of Metalloproteinase ADAM17 in Regulating ICOS Ligand–Mediated Humoral Immune Responses
- (2014) Joanna Marczynska et al. JOURNAL OF IMMUNOLOGY
- Blockade of IL-6TransSignaling Attenuates Pulmonary Fibrosis
- (2014) Thanh-Thuy T. Le et al. JOURNAL OF IMMUNOLOGY
- Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17)
- (2014) Hemant K. Mishra et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- The Multifaceted Functions of Neutrophils
- (2013) Tanya N. Mayadas et al. Annual Review of Pathology-Mechanisms of Disease
- Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17
- (2013) Jeanette Schwarz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice
- (2013) P M Vidal et al. Cell Death & Disease
- Hitting a complex target: an update on interleukin-6 trans-signalling
- (2012) Georg H Waetzig et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
- (2012) J. Hoge et al. JOURNAL OF IMMUNOLOGY
- The interleukin 6 pathway and atherosclerosis
- (2012) Jürgen Scheller et al. LANCET
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding
- (2011) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ADAM17 Activity and Other Mechanisms of Soluble L-selectin Production during Death Receptor-Induced Leukocyte Apoptosis
- (2010) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
- (2010) M. M. McFarland-Mancini et al. JOURNAL OF IMMUNOLOGY
- The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
- (2010) E. Jorissen et al. JOURNAL OF NEUROSCIENCE
- Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin
- (2008) Kai Kessenbrock et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started